Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

What The New US Cholesterol Treatment Guidelines Mean For Esperion

Executive Summary

Guidelines place high emphasis on low cost, but also outcomes data. Esperion plans to file bempedioc acid next year, but outcomes data won’t be available until 2022.

Advertisement

Related Content

Esperion Expects Preferred Formulary Placement For Oral Cholesterol Drug Bempedoic Acid
Amgen Drops Repatha List Price 60% To Cut Medicare Co-Pays And Boost Use
PCSK9 Turning Point? Sanofi/Regeneron Dangle Lower Price Carrot For Praluent
Time, And Price, Are Right To Prescribe Statins To the Masses

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC124187

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel